Recent Updates
Recently added Catalysts
CRON

Cronos Group Inc. Appoints Lead Director, Engages Investor Relations Agency and Grants Options TORONTO

Key Takeaway: Cronos Group Inc. Appoints Lead Director, Engages Investor Relations Agency and Grants Options TORONTO, May 18, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, annou

Full Press Release Details

Cronos Group Inc. Appoints Lead Director, Engages Investor
Relations Agency and Grants Options
TORONTO, May 18, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V:
CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated
cannabis group, announced today it has appointed Jim Rudyk as lead director and has entered into an engagement agreement to retain
Athena Advisors LLC ("Athena Advisors") as its agency of record for investor relations and corporate communications.
"Since joining the board, Jim has been an integral part
of our success and we are excited for his continued leadership and contribution," said Mike Gorenstein, CEO of Cronos Group.
"We are also very pleased to have engaged a seasoned professional to cultivate our corporate messaging and present Cronos'
story to a broad audience in an effective manner."
Athena Advisors is based in New York City and was founded
by Anna Shlimak who spent more than 6 years at the New York Stock Exchange, where she was responsible for communication and relationship
development with investors and sell side analysts. Most recently, Shlimak was the Head of Investor Relations at Quest Partners
LLC, a research driven alternative investment firm comprising more than US$1.5 billion in assets. Shlimak was responsible for business
development, investor reporting, marketing and communication initiatives. She received a MBA from Columbia Business School and
holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania. Apart from than the provision
of investor relations and corporate communication advisory services, Athena Advisors has no other relationship or interest in the
Company (other than any stock options issued as consideration for such services).
Athena Advisors will provide the Company with dedicated investor
relations and corporate communications services for monthly fees of approximately $17,400 for an initial term of 3 years. In addition,
the Company has granted stock options to subscribe to an aggregate of 200,000 common shares of the Company to Athena Advisors as
consideration for the investor relations and corporate communications services which are subject to the Company's stock option
plan with terms further described below. The fees payable to Athena Advisors for its services are expected to be paid by
the Company with available cash.
Company Grants Options
The Company has granted stock options to subscribe to an aggregate
of 1,195,000 common shares of the Company for certain directors, officers, consultants (including Athena Advisors), and employees
in accordance with the Company's stock option plan. The options are exercisable at a price of $7.57 per common share, which was
the closing price of the Company's common shares on the TSX Venture Exchange on May 17, 2018. The options shall expire at the earlier
of 180 days of the death, disability or incapacity of the holder, or five years after the date of issue. The grant of options is
subject to the Company receiving all necessary and appropriate regulatory consents and approvals, if any, and to the Company's
Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents. The Company
operates two wholly-owned Canadian licensed producers regulated under Health Canada's Access to Cannabis for Medical Purposes
Regulations: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health
Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia. The Company has multiple international production
and distribution platforms including in Germany, Israel and Australia. The Company intends to continue to rapidly expand its global
footprint as it focuses on building an international iconic brand portfolio and develop disruptive intellectual property. Cronos
Group is committed to building industry leading companies that transform the perception of cannabis and responsibly elevate the
consumer experience.
Forward-looking statements
This news release contains "forward-looking information" and "forward-looking statements" within the meaning
of applicable Canadian and U.S. securities laws. All information contained herein that is not clearly historical in nature
may constitute forward-looking information. In some cases, forward-looking statements can be identified by words or phrases
such as "may", "will", "expect", "plan", "anticipate", "intend", "potential",
"estimate", "believe" or the negative of these terms, or other similar expressions intended to identify forward-looking
statements. Some of the forward-looking statements contained in this press release, include the Company's intention to continue
to rapidly expand its global footprint, build an international iconic brand portfolio and develop disruptive intellectual property
and the sources of funds for payment of the fees payable to Athena Advisors. Forward-looking statements are necessarily based upon
a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business,
economic and competitive risks, uncertainties and contingencies that may cause actual financial results, performance or achievements
to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking
statements and the forward-looking statements are not guarantees of future performance. A discussion of some of the material
risks applicable to the Company can be found in the Company's current MD&A and Annual Information Form, both of which have
been filed on SEDAR and can be accessed at www.sedar.com. The forward-looking information included in this news release is made
as of the date of this news release and, except as required by law, Cronos Group disclaims any obligation to update or revise any
forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements.
All references to "$" are to Canadian dollars unless
otherwise specified.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy
SOURCE Cronos Group Inc.
For further information: Mike Gorenstein, Chief Executive
Officer, Tel: (416) 504-0004, investor.relations@thecronosgroup.com
CO: Cronos Group Inc.
CNW 08:00e 18-MAY-18
Last updated: May 18, 2018